Am Heart J
- SIREN M, Leivo J, Anttonen E, Jolly SS, et al
The Prognostic Significance of Single-Lead ST-Segment Resolution in ST-Segment
Elevation Myocardial Infarction Patients Treated with Primary PCI - A Substudy of
the Randomized TOTAL Trial.
Am Heart J. 2023 Dec 16:S0002-8703(23)00347-2. doi: 10.1016/j.ahj.2023.
- ANDERSEN CF, Larsen JH, Jensen J, Omar M, et al
Empagliflozin to elderly and obese patients with increased risk of developing
heart failure: Study protocol for the Empire Prevent trial program.
Am Heart J. 2024 Feb 14:S0002-8703(24)00032-2. doi: 10.1016/j.ahj.2024.
Am J Cardiol
- BRAUNWALD E
Hypertrophic Cardiomyopathy: A Brief Overview.
Am J Cardiol. 2024;212S:S1-S3.
- HUTT E, Desai MY
Medical Treatment Strategies for Hypertrophic Cardiomyopathy.
Am J Cardiol. 2024;212S:S33-S41.
- MARON BJ, Rowin EJ, Maron MS
Advances in the Management of Hypertrophic Cardiomyopathy Leading to Low
Disease-Related Mortality in 2023.
Am J Cardiol. 2024;212S:S77-S82.
- CHAMBERGO-MICHILOT D, Becerra-Gonzales VG, Kittipibul V, Colombo R, et al
Racial Differences in Hospice Care Outcomes Among Patients with Advanced Heart
Failure: Systematic Review and Meta-analysis.
Am J Cardiol. 2024 Feb 19:S0002-9149(24)00096.
BMJ
- WEI Y, Feng Y, Danesh Yazdi M, Yin K, et al
Exposure-response associations between chronic exposure to fine particulate
matter and risks of hospital admission for major cardiovascular diseases:
population based cohort study.
BMJ. 2024;384:e076939.
Circ Arrhythm Electrophysiol
- GONZALEZ-MATOS CE, Rodriguez-Queralto O, Zaraket F, Jimenez J, et al
Conduction System Stimulation to Avoid Left Ventricle Dysfunction.
Circ Arrhythm Electrophysiol. 2024;17:e012473.
Circ Cardiovasc Interv
- SHECHTER A, Lee M, Kaewkes D, Patel V, et al
Implications of Mitral Annular Calcification on Outcomes Following Mitral
Transcatheter Edge-to-Edge Repair.
Circ Cardiovasc Interv. 2024;17:e013424.
Circ Cardiovasc Qual Outcomes
- RAO BR, Dickert NW, Morris AA
Ethical Complexity of Medical Treatment Affordability and Clinical Trial
Diversity in Heart Failure.
Circ Cardiovasc Qual Outcomes. 2024;17:e010227.
Circ Heart Fail
- PARDO SANZ A, Salido Tahoces L, Jimenez-Blanco Bravo M, Alvarez Garcia J, et al
TAVI With ACURATE neo2 Valve in Aortic Regurgitation Due to Left Ventricular
Assist Device: A Custom-Made Option.
Circ Heart Fail. 2024 Jan 12:e010719. doi: 10.1161/CIRCHEARTFAILURE.123.010719.
- MYHRE PL, Omland T, Shah AM
Ongoing Enigma of NT-proBNP in HFpEF: Insights From Proteomics.
Circ Heart Fail. 2024;17:e011428.
- BITAR A, Colvin MM
Beyond Tiers: Examination of the French Heart Allocation System.
Circ Heart Fail. 2024;17:e011312.
- MOAYEDI Y, Rodenas-Alesina E, Somerset E, Fan CPS, et al
Enhancing the Prediction of Cardiac Allograft Vasculopathy Using Intravascular
Ultrasound and Machine Learning: A Proof of Concept.
Circ Heart Fail. 2024 Feb 5:e011306. doi: 10.1161/CIRCHEARTFAILURE.123.011306.
- ARABYARMOHAMMADI S, Yuan C, Viswanathan VS, Lal P, et al
Failing to Make the Grade: Conventional Cardiac Allograft Rejection Grading
Criteria Are Inadequate for Predicting Rejection Severity.
Circ Heart Fail. 2024;17:e010950.
Circ Res
- KAMRADT ML, Makarewich CA
CHKB-DT: A Long Noncoding RNA Critical for Cardiovascular Health.
Circ Res. 2024;134:442-444.
- VACCA A, Schiattarella GG
From Gut to Heart: Role of Indole-3-Propionic Acid in HFpEF.
Circ Res. 2024;134:390-392.
Clin Cardiol
- ERGUI I, Salama J, Hooda U, Ebner B, et al
In-hospital outcomes in unhoused patients with cardiogenic shock in the United
States: Insights from The National Inpatient Sample 2011-2019.
Clin Cardiol. 2024;47:e24235.
- ZHENG S, Li L, Jiang C, He L, et al
Association between performance measures and clinical outcomes in patients with
heart failure in China: Results from the HERO study.
Clin Cardiol. 2024;47:e24233.
Eur Heart J
- SCHMITTO JD, Shaw S, Garbade J, Gustafsson F, et al
Fully magnetically centrifugal left ventricular assist device and long-term
outcomes: the ELEVATE registry.
Eur Heart J. 2023 Nov 30:ehad658. doi: 10.1093.
Eur J Heart Fail
- PITT B, Iyer SPN, Humes HD
New opportunity for targeting systemic inflammation in patients with heart
failure through leucocyte immunomodulation.
Eur J Heart Fail. 2024 Feb 23. doi: 10.1002/ejhf.3177.
-
Correction to 'Congestion in heart failure: a circulating biomarker-based
perspective. A review from the Biomarkers Working Group of the Heart Failure
Association, European Society of Cardiology'.
Eur J Heart Fail. 2024 Feb 20. doi: 10.1002/ejhf.3171.
- PELLICORI P, Felker GM, Cleland JGF
Reply to 'Vasodilators in congestive heart failure: The perfect weapon aiming
just off the target?'.
Eur J Heart Fail. 2024 Feb 20. doi: 10.1002/ejhf.3159.
- TALHA KM, Januzzi JL Jr, Meng T, Greene SJ, et al
Use of natriuretic peptides and echocardiography for diagnosing heart failure.
Eur J Heart Fail. 2024 Feb 20. doi: 10.1002/ejhf.3165.
- MINAMISAWA M, Inciardi RM, Claggett B, Cikes M, et al
Clinical implications of subclinical left ventricular dysfunction in heart
failure with preserved ejection fraction: The PARAGON-HF study.
Eur J Heart Fail. 2024 Feb 18. doi: 10.1002/ejhf.3167.
- KHAN MS, Sperry BW, Butler J
Kidney involvement in transthyretin cardiac amyloidosis - Role of urinary albumin
to creatinine ratio and need for further evidence generation.
Eur J Heart Fail. 2024;26:74-76.
- BERTERO E, Chiti C, Schiavo MA, Tini G, et al
Real-world candidacy to mavacamten in a contemporary hypertrophic obstructive
cardiomyopathy population.
Eur J Heart Fail. 2024;26:59-64.
- SEOUDY H, Voran JC, Frank D
Growth differentiation factor-15 in sodium-glucose cotransporter 2 inhibition:
Mechanistic insights from the EMPEROR program.
Eur J Heart Fail. 2024;26:165-166.
- RIVAS GARCIA S, Alvarez-Garcia J
Sacubitril/valsartan: Where mechanism meets evidence-based medicine.
Eur J Heart Fail. 2024;26:127-129.
- FERREIRA JP, Rossello X, Zannad F
Mineralocorticoid receptor antagonist indication and underuse in high-risk
post-myocardial infarction patients.
Eur J Heart Fail. 2024;26:140-141.
- ARDISSINO M, Halliday BP, de Marvao A
The global landscape of peripartum cardiomyopathy: Morbidity, mortality, recovery
and inequity.
Eur J Heart Fail. 2024;26:43-45.
- IOANNOU A, Rauf MU, Patel RK, Razvi Y, et al
Albuminuria in transthyretin cardiac amyloidosis: Prevalence, progression and
prognostic importance.
Eur J Heart Fail. 2024;26:65-73.
- MERLO M, Setti M, Sinagra G
Coronary artery disease and dilated cardiomyopathy: Where parallel universes
merge.
Eur J Heart Fail. 2024;26:56-58.
- SCHOU M, Claggett B, Miao ZM, Fernandez A, et al
Sacubitril/valsartan compared to ramipril in high-risk post-myocardial infarction
patients stratified according to use of mineralocorticoid receptor antagonists:
Insight from the PARADISE MI trial.
Eur J Heart Fail. 2024;26:130-139.
- MAEDA D, Matsue Y, Dotare T, Sunayama T, et al
Clinical characteristics and prognosis of patients with isolated cardiac
sarcoidosis: Insights from the ILLUMINATE-CS study.
Eur J Heart Fail. 2024;26:77-86.
- JACKSON AM, Bauersachs J, Petrie MC, van der Meer P, et al
Outcomes at one year in women with peripartum cardiomyopathy: Findings from the
ESC EORP PPCM Registry.
Eur J Heart Fail. 2024;26:34-42.
- JONES RE, Hammersley DJ, Zheng S, McGurk KA, et al
Assessing the association between genetic and phenotypic features of dilated
cardiomyopathy and outcome in patients with coronary artery disease.
Eur J Heart Fail. 2024;26:46-55.
Heart
- GALLOO X, Fortuni F, Meucci MC, Butcher SC, et al
Association of right atrial strain and long-term outcome in severe secondary
tricuspid regurgitation.
Heart. 2023 Oct 30:heartjnl-2023-323084. doi: 10.1136/heartjnl-2023-323084.
- SANGHA V
Augmenting reality in echocardiography.
Heart. 2023 Nov 8:heartjnl-2023-323443. doi: 10.1136/heartjnl-2023-323443.
Hypertension
- TAKEDA R, Hissen SL, Akins JD, Washio T, et al
Sympathetic Neural Control at Rest and During the Cold Pressor Test in Patients
With Heart Failure With Preserved Ejection Fraction.
Hypertension. 2024 Feb 22. doi: 10.1161/HYPERTENSIONAHA.123.21918.
Int J Cardiol
- GARCIA-MOLL X, Lopez L
Safety of sacubitril/valsartan among older adults. Where real world data meet
clinical trials results.
Int J Cardiol. 2024;400:131706.
- DE SA MARCHI MF, van den Dorpel M, Calomeni P, Chatterjee S, et al
Comparative analysis of different risk prediction tools after mitral
Transcatheter edge-to-edge repair.
Int J Cardiol. 2024;400:131768.
- SRAYA R, Amsalem I, Carasso S, Gilad O, et al
Mitral valve gradient changes associate with outcomes of patients undergoing
transcatheter edge-to-edge repair.
Int J Cardiol. 2024 Jan 9:131766. doi: 10.1016/j.ijcard.2024.131766.
- DE MICHIELI L, Stoppa G, Sinigiani G, Previato L, et al
Hospitalization-based epidemiology of systemic and cardiac amyloidosis in the
Veneto Region, Italy.
Int J Cardiol. 2024;400:131804.
- MIGLIORE F, Schiavone M, Pittorru R, Forleo GB, et al
Left ventricular assist device in the presence of subcutaneous implantable
cardioverter defibrillator: Data from a multicenter experience.
Int J Cardiol. 2024 Jan 23:131807. doi: 10.1016/j.ijcard.2024.131807.
- XU L, Chen Y, Chen S, Wang G, et al
Relationship between resting heart rate and long-term outcomes in stabilized
patients with myocardial infarction: A prospective community-based cohort study.
Int J Cardiol. 2024 Jan 24:131811. doi: 10.1016/j.ijcard.2024.131811.
- SIM DKL, Mittal S, Zhang J, Hung CL, et al
Expert recommendations for the management of iron deficiency in patients with
heart failure in Asia.
Int J Cardiol. 2024 Feb 19:131890. doi: 10.1016/j.ijcard.2024.131890.
- GUAZZI M, Crisci G
Exercise mean PAP to CO relationship: An insightful endpoint for testing
therapeutic interventions in heart failure.
Int J Cardiol. 2024 Feb 20:131899. doi: 10.1016/j.ijcard.2024.131899.
- LUO Z, Gong X, Liu Y, Hao K, et al
Mitochondrial dysfunction due to miR-210/Drd5/ROS axis is a potential mechanism
of heart failure.
Int J Cardiol. 2024 Feb 20:131897. doi: 10.1016/j.ijcard.2024.131897.
J Am Coll Cardiol
- BOTTINOR W, Im C, Doody DR, Armenian SH, et al
Mortality After Major Cardiovascular Events in Survivors of Childhood Cancer.
J Am Coll Cardiol. 2024;83:827-838.
- BARIANI R, Rigato I, Celeghin R, Marinas MB, et al
Phenotypic Expression and Clinical Outcomes in Patients With Arrhythmogenic
Cardiomyopathies.
J Am Coll Cardiol. 2024;83:797-807.
J Card Fail
- PENG DM, Kwiatkowski DM, Lasa JJ, Zhang W, et al
Contemporary Care and Outcomes of Critically-ill Children With Clinically
Diagnosed Myocarditis.
J Card Fail. 2024;30:350-358.
- AMDANI S, Gupta D
Improving Outcomes for Critically Ill Children With Myocarditis.
J Card Fail. 2024;30:359-361.
- FIROZ A, Geier S, Yanagida R, Hamad E, et al
Heart Transplant Human Leukocyte Antigen Matching in the Modern Era.
J Card Fail. 2024;30:362-372.
- DEFILIPPIS EM, Lacelle C, Garg S, Farr M, et al
Harnessing Precision Medicine: HLA or Eplet Matching in Heart Transplantation.
J Card Fail. 2024;30:373-375.
- SHARIF SM, Smith JR, Bruhn EJ, Shultz AM, et al
Impact of Structured Resistance Training on Locomotor Muscle Composition in
Patients with HFpEF.
J Card Fail. 2024;30:410-414.
- ILONZE OJ, Pang PS
Nebulized Milrinone: Choosing Next Steps Wisely.
J Card Fail. 2024;30:337-339.
- FERREIRA JP, Neves JS, Saraiva F
Cardiovascular Prevention in Obese Patients Without Diabetes: Risk-based
Strategies Are Needed.
J Card Fail. 2024;30:418-420.
- LALA A, Hurt MT, Mentz RJ
The Heart as a Reminder for Oneness.
J Card Fail. 2024;30:317-318.
- FANG JC
A Board of Our Own: The New American Board for Cardiovascular Medicine.
J Card Fail. 2024;30:421.
- JUJIC A, Molvin J, Nilsson ED, Isholt HH, et al
Low levels of selenoprotein P associate with cognitive impairment in patients
hospitalized for heart failure.
J Card Fail. 2024 Feb 14:S1071-9164(24)00039.
- MARTYN T, Saef J, Bansal A, Martinez KA, et al
Patient and Provider Factors Associated With Initiating Sodium-Glucose
Cotransporter-2 Inhibitors (SGTL2i) Following FDA Approval for Heart Failure with
Preserved and Mildly Reduced Ejection Fraction.
J Card Fail. 2024 Feb 15:S1071-9164(24)00035.
J Cardiol
- SAITO S, Okubo S, Matsuoka T, Hirota S, et al
Impella - Current issues and future expectations for the percutaneous, microaxial
flow left ventricular assist device.
J Cardiol. 2024;83:228-235.
- YAKU H, Fudim M, Shah SJ
Role of splanchnic circulation in the pathogenesis of heart failure:
State-of-the-art review.
J Cardiol. 2024 Feb 16:S0914-5087(24)00022-4. doi: 10.1016/j.jjcc.2024.
J Mol Cell Cardiol
- ANTIPENKO S, Mayfield N, Jinno M, Gunzer M, et al
Neutrophils are indispensable for adverse cardiac remodeling in heart failure.
J Mol Cell Cardiol. 2024;189:1-11.
Lancet
- CAMPBELL P, Rutten FH, Lee MM, Hawkins NM, et al
Heart failure with preserved ejection fraction: everything the clinician needs to
know.
Lancet. 2024 Feb 14:S0140-6736(23)02756-3. doi: 10.1016/S0140-6736(23)02756.
PLoS Med
- HALL M, Smith L, Wu J, Hayward C, et al
Health outcomes after myocardial infarction: A population study of 56 million
people in England.
PLoS Med. 2024;21:e1004343.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016